24
Participants
Start Date
May 4, 2021
Primary Completion Date
May 11, 2021
Study Completion Date
May 11, 2021
simufilam
Simufilam 100 mg oral tablets: the Phase 3 oral tablet for the first 3 arms and the Phase 2 tablet for the 4th arm.
Worldwide Clinical Trials Phase I Unit, San Antonio
Lead Sponsor
Collaborators (1)
Worldwide Clinical Trials
OTHER
Cassava Sciences, Inc.
INDUSTRY